跳至主要内容
临床试验/TCTR20200803005
TCTR20200803005招募中2 期

Effects of Irvingia gabonensis kernel extract on fat oxidation rate, body mass, metabolism, oxidative stress, inflammation, and aerobic capacity in overweight or obese individuals

Blacmores company0 个研究点目标入组 72 人开始时间: 2020年8月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 59 Years(—)
性别
All

入选标准

  • •1)Men or women age between 30 and 59 years old
  • •2)BMI range between 23 and 29.9 kg/m2
  • •3)Stable weight (within four kilograms changed) at least three months before the supplementation phase
  • •4)Consistency of regular medicine such as hypertension and dyslipidemia drugs
  • •5)SGPT and creatinine levels less than 35 IU/L and 1 mg/dL respectively
  • •6)No attempt to reduce weight at least three months before the randomization
  • •7)Not taking any supplementation at least three months before the randomization.
  • •8)Non-smoker and alcohol drinker

排除标准

  • •1)Pregnancy
  • •2)Diagnosed with type 2 diabetes mellitus (fasting blood glucose > 126 mg/dL)
  • •3)Diagnosed with cardiovascular diseases except hypertension
  • •4)Cannot maintain regular medicines
  • •5)Diagnosed with neuromuscular disease
  • •6)Diagnosed with orthopedic problems and history of bone fracture
  • •7)Diagnosed with liver and kidney diseases
  • •8)Diagnosed with autonomic neuropathy
  • •9)Chronic infections (HIV, TB, Hepatitis)
  • •10)Diagnosed with endocrine diseases, thyroid conditions, polycystic ovary syndrome (PCOS)
  • •11)Had history with drug or natural ingredients allergy which was contained in the tablet

研究者

发起方
Blacmores company

相似试验